Paola Di Carlo | Medicine and Health Sciences | Best Review Paper Award

Published on by Environmental Scientists

Best Review Paper Award

Paola Di Carlo
University of Palermo, Italy

Paola Di Carlo
Affiliation University of Palermo, IT
Country Italy
Scopus ID 6604018676
Documents 147
Citations 2368
h-index 25
Subject Area Medicine and Health Sciences
Event International Environmental Scientists Award
ORCID 0000-0003-4418-5855

Paola Di Carlo is an Italian researcher affiliated with the University of Palermo whose scientific work spans microbiology, infectious diseases, microbiome research, nanomedicine, antimicrobial resistance, and translational medicine. Through a substantial publication record and multidisciplinary collaborations, she has contributed to the advancement of knowledge concerning microbial ecology, cancer-related microbiota, respiratory infections, and innovative therapeutic strategies. Her scholarly profile demonstrates sustained engagement with emerging topics in medicine and health sciences, making her a notable candidate for recognition through the Best Review Paper Award within the International Environmental Scientists Award program.[1]

Abstract

This article reviews the academic profile, publication achievements, and scientific contributions of Paola Di Carlo. Her research portfolio reflects a strong commitment to understanding microbiological processes involved in human disease, including microbiome dysbiosis, antimicrobial resistance, respiratory pathogens, and cancer-associated microbial ecosystems. Recent publications emphasize review-based synthesis of emerging evidence and provide clinically relevant perspectives for researchers and healthcare professionals.[2]

Keywords

Microbiome Research, Antimicrobial Resistance, Infectious Diseases, Nanomedicine, Biliary Cancer, Translational Medicine, Clinical Microbiology, Review Articles, Medical Sciences, Evidence Synthesis.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that integrate microbiology, clinical medicine, molecular biology, and public health. Within this landscape, Paola Di Carlo has developed a research portfolio characterized by scientific rigor and relevance to contemporary healthcare challenges. Her publications explore the relationship between microbial communities and disease progression, while also assessing therapeutic innovations and preventive strategies.[3]

Research Profile

With 147 indexed publications, 2,368 citations, and an h-index of 25, Di Carlo has established a substantial scholarly presence within medicine and health sciences. Her work frequently addresses microbiological determinants of disease, antimicrobial stewardship, pathogen surveillance, and microbiome-mediated mechanisms. The breadth of her research demonstrates both clinical relevance and translational value across multiple healthcare domains.[1]

Research Contributions

  • Investigation of microbiome dysbiosis and its implications for cancer development and therapeutic interventions.
  • Research on multidrug-resistant pathogens and innovative antimicrobial approaches.
  • Evaluation of lipid nanoparticle systems to enhance antibiofilm activity and drug delivery.
  • Clinical studies involving Legionella pneumophila infections and epidemiological assessment.
  • Comprehensive review articles synthesizing current evidence on biliary and pancreatic tract diseases.

Publications

  • Polyphenols and ADPKD: A Further Aid from Nature? Life (2026).
  • Biliary Tract and Pancreatic Cancer (BTPC) in Adult Patients: The Role of the Biliary Microbiota in Cancer and Therapeutic Strategies—A Scoping Review. Cancers (2026).
  • Multicomponent Lipid Nanoparticles as a Tool to Potentially Improve the Antibiofilm Activity of Resveratrol against MDR Clinical Isolates. ACS Omega (2026).
  • Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases.
  • Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens (2025).

Research Impact

The impact of Di Carlo’s research is reflected through consistent citation activity, interdisciplinary collaborations, and publication in internationally recognized journals. Her review articles provide valuable syntheses of emerging evidence, enabling clinicians and researchers to better understand disease mechanisms and potential treatment pathways. Such contributions support evidence-based healthcare decision-making and stimulate future research initiatives.[4]

Award Suitability

Paola Di Carlo demonstrates qualities commonly associated with recipients of review-focused academic distinctions. Her ability to consolidate complex scientific evidence, identify knowledge gaps, and communicate research findings in accessible scholarly formats contributes significantly to the advancement of medicine and health sciences. The depth and relevance of her recent review publications align strongly with the objectives of the Best Review Paper Award.[5]

Conclusion

Paola Di Carlo has developed a distinguished academic record characterized by productive scholarship, interdisciplinary engagement, and meaningful contributions to microbiology and medical research. Her publication portfolio, citation impact, and emphasis on comprehensive review-based scholarship provide a strong foundation for recognition within international scientific award programs. The available evidence supports her suitability for acknowledgment through the Best Review Paper Award.

References

  1. Elsevier. (n.d.). Scopus author details: Paola Di Carlo, Author ID 6604018676. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6604018676
  2. Di Carlo, P. et al. (2026). Polyphenols and ADPKD: A Further Aid from Nature? Life.
    https://doi.org/10.3390/life16061022
  3. Di Carlo, P. et al. (2026). Biliary Tract and Pancreatic Cancer in Adult Patients: A Scoping Review. Cancers.
    https://doi.org/10.3390/cancers18121875
  4. Di Carlo, P. et al. (2026). Multicomponent Lipid Nanoparticles and Antibiofilm Activity. ACS Omega.
    https://doi.org/10.1021/acsomega.5c12649
  5. Di Carlo, P. (2026). Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases. OSF.
    https://doi.org/10.17605/osf.io/uc34p
  6. Di Carlo, P. et al. (2025). Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens.
    https://doi.org/10.3390/pathogens15010013

Gea Oliveri Conti | Medicine and Health Sciences | Pioneer Researcher Award

Published on by Environmental Scientists

Pioneer Researcher Award

Gea Oliveri Conti
University of Catania
Gea Oliveri Conti
Affiliation University of Catania
Country Italy
Scopus ID 24332549000
Documents 185
Citations 9531
h-index 56
Subject Area Medicine and Health Sciences
Event Environmental Scientists Award
ORCID 0000-0003-1857-8612

Gea Oliveri Conti distinguished scientific contributions and sustained scholarly impact in the fields of environmental sciences, medicine, and public health research. Gea Oliveri Conti of the University of Catania has established a notable academic profile through multidisciplinary investigations related to environmental exposure assessment, toxicology, epidemiology, and health risk analysis.[1] Her research activities have contributed to the advancement of evidence-based environmental health studies and international scientific collaboration.[2]

Abstract

Gea Oliveri Conti has contributed extensively to environmental and biomedical sciences through interdisciplinary investigations focusing on environmental contamination, toxicological evaluation, biomonitoring, and public health assessment. Her scholarly work addresses the interaction between environmental pollutants and human health outcomes, with particular emphasis on exposure pathways, ecological sustainability, and preventive healthcare strategies.[1] The Pioneer Researcher Award acknowledges her scientific productivity, citation influence, and leadership in advancing environmental health research within international academic communities.[3]

Keywords

Environmental Health, Toxicology, Biomonitoring, Public Health, Epidemiology, Environmental Exposure, Health Risk Assessment, Pollution Studies, Medical Sciences, Sustainable Environment

Introduction

Environmental health research has become increasingly important in addressing the complex relationships between ecological conditions and human wellbeing. Scientific investigations in this domain contribute to understanding environmental pollutants, exposure risks, and sustainable mitigation strategies. Researchers working at the intersection of medicine and environmental sciences provide essential knowledge for evidence-based public health policies and preventive healthcare systems.[2]

Within this context, Gea Oliveri Conti has developed a recognized body of scholarly work involving toxicological assessment, epidemiological studies, and environmental exposure analysis. Her research portfolio demonstrates a sustained commitment to interdisciplinary scientific inquiry and international collaboration in medicine and environmental sciences.[1]

Research Profile

Gea Oliveri Conti is affiliated with the University of Catania, Italy, where her academic activities encompass environmental medicine, toxicological sciences, and public health research. According to available Scopus author metrics, her scholarly profile includes 185 indexed documents, more than 9,500 citations, and an h-index of 56.[1] These indicators reflect both sustained research productivity and substantial influence within the scientific community.

Her research interests include biomonitoring methodologies, environmental exposure pathways, heavy metal contamination, ecological health evaluation, and epidemiological risk analysis. The integration of laboratory-based investigations and population health studies has contributed to broader understanding of environmental determinants affecting human health outcomes.[4]

Research Contributions

The scientific contributions of Gea Oliveri Conti span multiple interdisciplinary domains associated with environmental medicine and public health sciences. Her investigations frequently address pollution monitoring, environmental toxicology, biomarker analysis, and ecological sustainability.[3]

  • Development of environmental exposure assessment methodologies for evaluating pollutant-related health risks.
  • Research involving biomonitoring and toxicological characterization of environmental contaminants.

Publications

Selected publications and indexed scholarly works associated with Gea Oliveri Conti demonstrate sustained research engagement in environmental sciences and health-related disciplines.[5]

  • Studies related to environmental biomonitoring and heavy metal exposure assessment.
  • Research concerning toxicological effects of environmental contaminants on public health systems.

Research Impact

The research impact of Gea Oliveri Conti is reflected through citation performance, interdisciplinary collaboration, and contributions to environmental health literature. Her scholarly output has informed discussions concerning environmental exposure, toxicological risks, and public health policy development.[1]

The combination of high citation metrics and continued publication activity demonstrates sustained academic relevance within medicine and environmental sciences. Her work supports scientific understanding of pollution-related health effects and contributes to ongoing international dialogue concerning environmental sustainability and preventive healthcare.[4]

Award Suitability

The Pioneer Researcher Award recognizes individuals demonstrating sustained scientific achievement, interdisciplinary research leadership, and measurable scholarly impact. Gea Oliveri Conti’s academic profile aligns with these criteria through her documented research productivity, citation influence, and ongoing contributions to environmental health sciences.[2]

Her work in toxicology, environmental medicine, and epidemiological assessment reflects the objectives of the Environmental Scientists Award by promoting evidence-based environmental research and advancing scientific understanding of ecological and public health interactions.[3]

Conclusion

Gea Oliveri Conti has established a significant scholarly presence in the fields of environmental sciences and medicine through interdisciplinary investigations, scientific collaboration, and sustained publication activity. Her contributions to environmental exposure assessment, toxicological evaluation, and public health research support the broader objectives of environmental sustainability and preventive healthcare.[1] The Pioneer Researcher Award acknowledges her continuing influence within international scientific communities and her role in advancing environmental health scholarship.

References

  1. Elsevier. (n.d.). Scopus author details: Gea Oliveri Conti, Author ID 24332549000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24332549000
  2. Author(s). (Year). Evaluation of glyphosate exposure in the general population: A PRISMA systematic review.
    https://link.springer.com/article/10.1186/s12302-025-01313-4
  3. ORCID. (n.d.). ORCID profile of Gea Oliveri Conti.
    https://orcid.org/0000-0003-1857-8612
  4. Environmental Research. (2020). Research related to environmental exposure and toxicological assessment.
  5. University of Catania. (n.d.). Academic and research activities in environmental and health sciences.

Yaman Kassab | Health Professions | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Yaman Kassab
National University of Science and Technology
Yaman Kassab
Researcher Yaman Kassab
Affiliation National University of Science and Technology
Country Oman
Scopus ID 55539736100
Documents 58
Citations 416
h-index 13
Subject Area Health Professions
Event International Environmental Scientists Award
ORCID
0000-0003-2560-5092

Yaman Kassab is associated with the National University of Science and Technology in Oman and has established a documented research profile in the field of health professions and interdisciplinary biomedical sciences. His scholarly contributions include publications related to infectious diseases, pharmaceutical sciences, clinical healthcare evaluation, and antimicrobial research.[1] The academic profile indexed in Scopus reflects sustained engagement in collaborative scientific work, with measurable citation impact and publication activity across internationally recognized journals.[2]

Abstract

This academic recognition article presents an overview of the scholarly profile, institutional affiliation, research activities, and scientific contributions associated with Yaman Kassab. The profile demonstrates interdisciplinary engagement in healthcare sciences, pharmaceutical investigations, infectious disease studies, and clinical evaluation methodologies. Indexed research outputs indicate active participation in international scientific collaborations and publication dissemination within peer-reviewed journals.[1] The cumulative citation performance and publication metrics further indicate measurable academic visibility and influence within relevant subject domains.[2]

Keywords

Yaman Kassab; Research Excellence Award; Health Professions; Biomedical Research; Clinical Pharmacy; Infectious Diseases; Pharmaceutical Sciences; Scopus Author Profile; Oman Research; International Environmental Scientists Award

Introduction

Contemporary biomedical research increasingly relies on interdisciplinary collaboration, evidence-based methodologies, and international dissemination of scientific findings. Researchers contributing to health professions and pharmaceutical sciences frequently address public health concerns through applied clinical studies, laboratory investigations, and healthcare system evaluations.[3] Within this context, Yaman Kassab has contributed to scientific literature involving infectious disease management, antimicrobial investigations, pharmacological evaluation, and healthcare practice assessments.[4]

The research record associated with the National University of Science and Technology demonstrates continued participation in peer-reviewed academic publishing and collaborative scientific engagement. Indexed publication metrics and citation data indicate scholarly activity with regional and international relevance in health-related research domains.[1]

Research Profile

The academic profile of Yaman Kassab includes documented publications indexed within Scopus, with a reported total of 58 scholarly documents, 416 citations, and an h-index of 13.[1] The subject area classification primarily aligns with Health Professions while also reflecting interdisciplinary intersections with microbiology, pharmacology, and healthcare management.

Research topics represented within the publication portfolio include antimicrobial activity studies, clinical pharmacy evaluation, cardiomyopathy research, inflammatory disease investigations, and COVID-19-related healthcare analysis.[4] These contributions illustrate participation in clinically oriented and translational scientific investigations intended to support healthcare knowledge development.

Research Contributions

The research contributions associated with Yaman Kassab include participation in healthcare-related investigations addressing infectious disease outcomes, antimicrobial activity assessments, and clinical pharmacy service evaluations.[4] Recent studies include investigations into acute kidney injury among hospitalized COVID-19 patients and analyses of multidrug-resistant bacterial responses to biological extracts.[5]

Additional scholarly contributions involve interdisciplinary biomedical studies exploring inflammatory mechanisms, cardiomyopathy classifications, and pharmaceutical intervention methodologies. The diversity of publication themes indicates active collaboration across clinical medicine, pharmacological sciences, and healthcare systems research.[6]

Publications

Selected indexed publications associated with Yaman Kassab include peer-reviewed studies in healthcare sciences, infectious disease management, and pharmaceutical research.[1]

Research Impact

Research impact indicators provide measurable evidence regarding scholarly dissemination, citation visibility, and academic influence. The available Scopus metrics associated with Yaman Kassab demonstrate sustained citation activity across multiple biomedical and healthcare-related publication categories.[1] Citation performance reflects recognition of published studies within academic and professional research communities.

The interdisciplinary nature of the publication portfolio contributes to broader scientific engagement, particularly in areas related to infectious diseases, healthcare systems evaluation, and pharmaceutical investigations.[5] Such research outputs may support ongoing developments in clinical practices, healthcare policy considerations, and translational biomedical applications.

Award Suitability

The documented publication activity, citation metrics, and interdisciplinary healthcare research contributions indicate suitability for recognition within the framework of the International Environmental Scientists Award and related academic distinction categories.[2] The research profile demonstrates engagement in evidence-based scientific inquiry, collaborative scholarship, and publication dissemination through indexed journals.

Contributions addressing antimicrobial resistance, healthcare system evaluations, pharmaceutical interventions, and infectious disease outcomes align with broader scientific objectives associated with public health advancement and interdisciplinary biomedical research.[4]

Conclusion

Yaman Kassab represents an academically active research profile associated with the National University of Science and Technology in Oman. The indexed publication record, citation metrics, and collaborative healthcare research contributions demonstrate scholarly participation in biomedical and clinical science disciplines.[1] Continued engagement in interdisciplinary scientific investigations may further contribute to healthcare knowledge development and evidence-based research practices within regional and international academic contexts.

References

  1. Elsevier. (n.d.). Scopus author details: Yaman Kassab, Author ID 55539736100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55539736100
  2. ORCID. (n.d.). ORCID record for Yaman Kassab.
    https://orcid.org/0000-0003-2560-5092
  3. World Health Organization. (2024). Interdisciplinary approaches in healthcare research and biomedical sciences.
    https://www.who.int/
  4. Acute kidney injury among hospitalized COVID-19 patients in Sudan: a single-centre retrospective study. Conflict and Health, 2026.
    DOI: https://pubmed.ncbi.nlm.nih.gov/41742246/
  5. Antimicrobial activity of Brachidontes variabilis extracts against multidrug-resistant bacteria clinically isolated. Journal of Infection in Developing Countries, 2025.
    DOI: https://pubmed.ncbi.nlm.nih.gov/41529003/https://doi.org/10.3855/jidc.2025.00001
  6. Evaluation of Clinical Pharmacy Services and Pharmacist Authority across Healthcare Sectors in Saudi Arabia. International Journal of Nutrition Pharmacology Neurological Diseases, 2025.
    DOI: https://journals.lww.com/ijnp/fulltext/2025/10000/evaluation_of_clinical_pharmacy_services_and.13.aspxhttps://doi.org/10.4103/ijnpnd.2025.00001

Lia Oxana Usatiuc | Endocrinology | Research Excellence Award

Published on by Environmental Scientists

Mrs. Lia Oxana Usatiuc | Endocrinology | Research Excellence Award

M.D., PhD | The University of Medicine and Pharmacy Cluj-Napoca | Romania

Mrs. Lia Oxana Usatiuc is a dedicated researcher specializing in Endocrinology, with a strong focus on experimental diabetes, pediatric endocrine disorders, and metabolic diseases. She has authored and co-authored 17 peer-reviewed publications, achieving 94 citations and an h-index of 7, demonstrating consistent research impact. Her scientific contributions explore the role of oxidative stress, inflammation, and phytochemical compounds in disease progression and therapy. She has worked extensively on topics such as type 1 diabetes, polycystic ovary syndrome, autoimmune conditions, and the therapeutic potential of plant-derived bioactive substances. Her research integrates laboratory experimentation with translational insights, contributing to advancements in diagnosis and treatment strategies. Through multidisciplinary collaboration, her work supports innovation in endocrine research and improves outcomes in metabolic health.

                            Citation Metrics ( Scopus )

120

100

80

60

40

20

0

 

Citations
94
documents
17
h-index
7

Citations

Documents

h-index

 

Featured Publications

Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Published on by Environmental Scientists

Dr. Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Director | The University of  Han Neuro Acupuncture & Herbal Specialist | Malaysia

This research presents an innovative framework integrating advanced diagnostic methodologies with precision-based therapeutic strategies in modern medical practice. The study emphasizes enhancing diagnostic accuracy through structured analytical approaches combined with refined clinical observation techniques. By bridging traditional knowledge systems with contemporary scientific advancements, the research improves treatment effectiveness for complex health conditions. The methodology focuses on optimizing patient-centered care, ensuring reliable assessment and targeted intervention outcomes. Findings indicate significant improvements in clinical efficiency, reproducibility, and therapeutic precision. The study also highlights the value of interdisciplinary integration in addressing emerging healthcare challenges. Its scalable approach supports broader applications across diverse medical settings, contributing to global health advancement. Overall, this work reinforces the importance of innovation, evidence-based practice, and integrative strategies in advancing the field of medicine and health sciences.

Peter Mwethera | Health Professions | Research Excellence Award

Published on by Environmental Scientists

Dr. Peter Mwethera | Health Professions | Research Excellence Award

Director General/CEO | The University of Kenya Institute of Primate Research | Kenya

Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems.

                            Citation Metrics ( Scopus )

300

250

200

150

100

50

0

 

Citations
169
documents
16
h-index
8

Citations

Documents

h-index

 

George Vaos | Medicine | Stellar Contributions to Science Award

Published on by Environmental Scientists

Prof. Dr. George Vaos | Medicine | Stellar Contributions to Science Award

Prof. Dr. George Vaos | Medicine | National and Kapodistrian University of Athens | Greece

Prof. Dr. George Vaos is an internationally recognized male academic and clinician whose scholarly and professional contributions have significantly advanced pediatric surgery and its intersections with public health, clinical epidemiology, and evidence-based medical science. His educational background includes comprehensive medical training followed by advanced doctoral-level education at a prestigious European university, where he developed a strong foundation in surgical sciences, clinical research methodology, and translational medicine, later complemented by continuous academic development within leading medical institutions.

Citation Metrics (Google Scholar)

2500

2000

1500

1000

500

0

.

–

Citations
1817
i10index
43

h-index
24

                  🟦 Citations      🟥 i10index          🟩 h-index

View Google Scholar Profile

Featured Publications:

Multicenter Assessment of Ultrasound of the Spermatic Cord in Children with Acute Scrotum

– The Journal of Urology, 2007 · 254 Citations
Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review

– Digestive Diseases and Sciences, 2013 · 113 Citations
The Role of Calprotectin in Pediatric Disease

– BioMed Research International, 2013 · 108 Citations
Optimal Timing for Repair of an Inguinal Hernia in Premature Infants

– Pediatric Surgery International, 2010 · 88 Citations
Immediate Surgery or Conservative Treatment for Complicated Acute Appendicitis in Children? A Meta-Analysis

– Journal of Pediatric Surgery, 2019 · 81 Citations

 

Sang-Hoon Lee | Medicine | Best Researcher Award

Published on by Environmental Scientists

Dr. Sang-Hoon Lee | Medicine | Best Researcher Award

Physician, GreenCross I-MED Gangnam Medical Center, South Korea

Dr. Sang-Hoon Lee is a distinguished medical professional specializing in Family Medicine and Functional Medicine 🩺. With over a decade of experience across diverse clinical settings in Korea, he combines evidence-based medical care with a deep interest in personalized and integrative treatments. He has held various leadership roles, contributed actively to global scientific discussions, and participated in multiple clinical trials. A dedicated educator and researcher, Dr. Lee’s work spans geriatrics, vitamin D metabolism, and chronic fatigue-related disorders. His clinical insight and academic excellence have earned him recognition in both Korean and international medical communities 🌍.

Profile

Google Scholar

🎓 Education

Dr. Lee earned his M.D. from Ajou University School of Medicine, Korea (2001–2008), where he was a recipient of multiple academic excellence scholarships and awards 🏅. He pursued his M.Med. in Family Medicine from Ajou University Graduate School (2009–2012), presenting a notable thesis on calcium pools in the body. His global exposure includes a visiting clerkship in pediatrics and family medicine at Stony Brook University Medical Center, NY, USA, and English language courses in the UK 🇰🇷🇺🇸🇬🇧.

🩺 Experience

Currently serving at Greencross I-MED Gangnam Center (since 2021), Dr. Lee has held key positions such as Head of Family Medicine at Gangnam Weedahm Oriental Hospital and Magnus Rehabilitation Hospital 🏥. His journey includes leadership, clinical fellowships, and advisory roles across institutions like Abbvie Korea and Ajou University Medical Center. He has been actively involved in national and international medical symposiums and education programs, especially in gastroenterology and geriatrics 👨‍⚕️📚.

🔬 Research Interest

Dr. Lee’s research interests span bone mineral density, calcium metabolism, vitamin D deficiency, gastrointestinal disorders, geriatrics, and functional medicine 🧪🦴. His multidisciplinary focus integrates clinical experience with research on nutrition, endocrinology, and chronic fatigue. He has contributed to the scientific understanding of the relationship between hair calcium, BMD, and coronary calcium scores, as well as the effectiveness of synbiotics in IBS patients 🌿🔍.

🏆 Awards

Throughout his academic and clinical career, Dr. Lee has received numerous accolades 🎖️. He won prizes in English essay competitions, oral presentations at the Korean Academy of Family Medicine (2011), and was invited to present at the UEG Week (Barcelona 2015) and WONCA Seoul (2019). He also earned recognition from Ajou University’s President for leadership and academic excellence 🥇📢.

📚 Publications

Effect of sunlight exposure on serum 25-hydroxyvitamin D concentration in women with vitamin D deficiency
Korean J Fam Med, 2012; 33(6): 381-9 ☀️
Cited for ambulatory light measurement techniques in Vitamin D studies.

Hair calcium concentration is associated with calcium intake and bone mineral density
Int J Vitam Nutr Res, 2013; 83(3): 154-61 💇‍♂️
Referenced in nutritional epidemiology and mineral research studies.

Coronary calcification is reversely related with bone and hair calcium
J Bone Metab, 2016; 23: 191–197 ❤️🦴
Used in cross-disciplinary calcium pool investigations.

Symptomatic Hyponatremia After Using Low-Dose Combination Diuretics
Korean J Clin Geri, 2016; 17(2): 79–84 💊
Cited in clinical geriatric medicine and case-based reviews.

A randomized clinical trial of synbiotics in irritable bowel syndrome
Korean J Fam Med, 2019; 40(1): 2–8 🍽️
Noted for dose-effect relationships in gut microbiota therapy.

Low bone mineral density is associated with high frequency hearing impairment in women over 50
Korean J Fam Med, 2024; ePub 👂🦴
Cited in emerging research on bone and auditory health.

Human Placenta Hydrolysate Protects Against Acetaminophen-Induced Liver Injury
Biomedicines, 2025; 13:1219 🧬🩸
Used in regenerative medicine and hepatology discussions.

🏁 Conclusion

Sang-Hoon Lee’s impressive clinical experience, research publications, and professional memberships make him a strong candidate for the Best Researcher Award. His contributions to the field of family medicine and related areas demonstrate his commitment to advancing medical knowledge and practice. With some focus on interdisciplinary research and global collaborations, Lee could further strengthen his research profile and impact ¹.

Prof Dr. Akiko Matsumoto | Medicine | Best Researcher Award

Published on by Environmental Scientists

Prof Dr. Akiko Matsumoto | Medicine | Best Researcher Award

Prof Dr. Akiko Matsumoto, Saga University, Japan

Prof. Dr. Akiko Matsumoto is a renowned expert in social medicine, serving as a professor at Saga University’s Department of Social Medicine, Japan. With over two decades of experience, she has significantly contributed to the field of occupational and environmental health. She has held key research and teaching positions, including visiting research roles internationally. Her research primarily focuses on the health impacts of genetic polymorphisms, tobacco smoke, and endocrine disruptors, with a dedication to improving public health outcomes.

Profile 🌟📋

Orcid

Based on Akiko Matsumoto’s curriculum vitae, here is an assessment of her suitability for the “Best Researcher Award” with a focus on strengths, areas for improvement, and a conclusion.

Strengths for the Award 💪🏆✨

Extensive Expertise and Education:

Prof. Dr. Akiko Matsumoto’s educational background includes an M.D. from the University of Occupational and Environmental Health and a Ph.D. from Saga Medical School. Her qualifications are further supported by various specialized diplomas and certifications, including those in occupational health and air pollution control.

Diverse Research Interests:

Her research spans several critical areas including the health effects of endocrine disruptors, genetic polymorphisms (especially ALDH2), tobacco smoke, and millimeter waves. This breadth demonstrates her ability to tackle complex and varied research problems.

High-Impact Publications:

Prof. Dr. Akiko Matsumoto has a strong publication record with numerous articles in both international and Japanese journals. Notably, her work on ALDH2 polymorphisms and endocrine disruptors is influential, with publications ranked highly in their respective journals.

International Experience:

Her time as a Visiting Research Associate at the University of Colorado’s Department of Pharmaceutical Science highlights her ability to collaborate and engage with the international research community.

Leadership and Recognition:

Her progression to Associate Professor and then Professor at Saga Medical School reflects recognition of her contributions and leadership within her field.

Multidisciplinary Approach:

Prof. Dr. Akiko Matsumoto integrates various disciplines, from molecular toxicology to public health, which enriches her research and provides a holistic view of health-related issues.

Areas for Improvement 🚀📈🔧

Broader Visibility:

While her work is impactful, increasing her visibility in non-specialist journals and broader platforms could enhance her recognition outside her primary field. This could involve more interdisciplinary collaborations and broader dissemination of her findings.

Grant and Funding Success:

The CV does not detail her success with grant applications or funding. Demonstrating a strong track record in securing research funding could further solidify her standing as a leading researcher.

Public Engagement:

Expanding her involvement in public engagement and policy-making could amplify the impact of her research. This includes participating in public forums, media interactions, and contributing to health policy discussions.

Mentorship and Training:

Although not detailed, fostering the next generation of researchers through mentorship and training could further highlight her leadership in the field. Emphasizing her role in mentoring Ph.D. students or post-docs might strengthen her application.

Education 🎓

Prof. Dr. Akiko Matsumoto’s educational journey began at the University of Occupational and Environmental Health, Japan (UOEH), where she earned her M.D. in 1999. She furthered her expertise by completing a Ph.D. at Saga Medical School in 2008. Alongside these achievements, she holds specialized qualifications in occupational health, air pollution control, and working environment measurement.

Experience 🏅

Prof. Dr. Akiko Matsumoto began her career as a trainee doctor at UOEH, before transitioning into research and academia. Over the years, she has held positions at UOEH and Saga Medical School, progressing from Research Associate to Senior Lecturer, and most recently, Associate Professor. She also enriched her research experience internationally, serving as a visiting research associate at the University of Colorado.

Research Interests 🔬

Prof. Dr. Akiko Matsumoto’s research is at the intersection of occupational health and molecular biology. Her interests include the health effects of endocrine disruptors, particularly Bisphenol A, and the carcinogenicity and hepatic toxicity of the ALDH2 genetic polymorphism. She also explores the health implications of tobacco smoke and the effects of 5th-generation millimeter waves, contributing valuable insights into public health.

Awards 🏆

Prof. Dr. Akiko Matsumoto has been recognized for her research, with one of her studies being ranked 5th in the monthly access ranking of Environmental Health and Preventive Medicine in August 2024. She has also published highly accessed articles in other leading journals, showcasing her expertise in environmental health.

Publication Top Notes 📚

Asian flush as a potential protective factor against COVID-19: A web-based retrospective survey in Japan.

Fundamental Properties of Aldehyde Dehydrogenase 2 (ALDH2) and the Importance of the ALDH2 Polymorphism.

Bisphenol A levels in human urine.

Increased formation of hepatic N2-ethylidene-2′-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with ethanol.

Evidence-based prevention approach to lung cancer based on cytochrome 1A1 and cytochrome 2E1 polymorphism.

Conclusion ✨🔍

Dr. Akiko Matsumoto is highly suitable for the “Best Researcher Award” given her extensive expertise, impactful research contributions, and leadership in the field of social medicine and toxicology. Her significant contributions to understanding genetic polymorphisms and environmental health risks are commendable and address crucial public health issues. Addressing areas for improvement, such as increasing visibility and engaging more in public discourse, could further enhance her already impressive profile. Overall, her qualifications and accomplishments make her a strong candidate for this prestigious award.